Shares of Beta Bionics fell after the maker of insulin-delivery systems shared preliminary data for new patient starts that were below expectations. The stock slipped 36%, to $20.5, on Friday. Over ...

The downgrade comes after the Irvine-based medical device company reported preliminary fourth quarter results.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of ...

IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary, ...

Ekso Bionics (EKSO) shares nearly doubled on Dec. 30 after Applied Digital (APLD) revealed plans of spinning off its cloud ...

Beta Bionics (BBNX) reported preliminary, unaudited Q4 2025 net sales of at least $32M, compared to estimate of $28.9M, ...

In 2024, medtech IPOs began to come back, thanks to the likes of heart valve company Anteris Technologies and neurotech ...

Ekso Bionics stock rises after non-binding term sheet with Applied Digital to merge cloud computing units into ChronoScale ...

According to the World Stroke Organization, one-in-four people will suffer a stroke at some point in their life.

EKSO Bionics shares surged after Applied Digital agreed to spin off its cloud business and combine it with EKSO. Shares climbed 64% to $8.91 in after-hours trading Monday. Through the close, the stock ...

Generative Bionics, an Italian company developing Physical AI powered humanoid robots, unveiled its first concept at CES 2026 ...